1 / 78

Antihypertensives , Anticoagulants, and Antidepressants:

Antihypertensives , Anticoagulants, and Antidepressants:. Important Dental Implications Ann R. Witham, D.V.M. Learning Objectives: What you will (hopefully) be able to do after this talk. How to perform risk assessment How to know when to refer

jwilkin
Télécharger la présentation

Antihypertensives , Anticoagulants, and Antidepressants:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Antihypertensives, Anticoagulants, and Antidepressants: Important Dental Implications Ann R. Witham, D.V.M.

  2. Learning Objectives: What you will (hopefully) be able to do after this talk • How to perform risk assessment • How to know when to refer • How to manage and prevent complications when treating patients on: • Antihypertensive medications • Anticoagulants • Antidepressants

  3. Hypertension: The Silent Killer. Hypertension defined: • Chronic illness, affects > 1 billion worldwide • One of leading risk factors for cardiovascular disease mortality • Systolic BP of 140 mm Hg or diastolic BP ≥ 90 mm Hg • BP readings elevated on at least 2 occasions with or without provocation

  4. Two Main Types of Hypertension • Primary: 90-95% of all • Secondary: caused by • vascular diseases • Cushing’s syndrome • Sleep apnea, hormonal dysfunction, substance abuse, alcohol consumption, contraceptive use, and chronic kidney disease

  5. Risk Factors for Primary Hypertension? • How many can you name? • Shout out!

  6. Risk Factors • Diabetes • Reduced nephron number • Family history • Age • Contraceptive use/menopause • Excessive alcohol consumption • Dyslipidemia • High sodium diet • Physical inactivity • Low education • Socioeconomic status • Obesity • Race • Personality traits/depression • Hypovitaminosis D • Tobacco use • Stress

  7. BP = Cardiac Output x Peripheral Resistance BP = (Heart Rate x Stroke Volume) x Peripheral Resistance To alter BP, you must alter either HR, SV, or PR.

  8. Key Regulators of Blood Pressure • Sympathetic nervous system • Renal system related to blood volume • Renin angiotensin aldosterone mechanism Antihypertensive drugs act on one or more of these control mechanisms.

  9. Consequences of Hypertension • Damages vasculature. • Damages major organs ( including kidneys), eventually causes HF • Increased morbidity and mortality

  10. Main Categories of Antihypertensives • Diuretics – • Beta-blockers • Angiotensin-converting enzyme inhibitors (ACEI’s) • Angiotensin II receptor blockers • Calcium channel blockers (CCB’s) • Alpha blockers • Alpha 2 agonists • Vasodilators • Others!!

  11. Diuretics • How do they work? • Increase urine production  decrease blood volume  decrease stroke volume (SV)  decrease blood pressure

  12. Diuretics • Act by increasing the amount of sodium ions and water that are excreted by the kidneys into the urine • Three major classes of diuretics • Thiazides • Loop diuretics • Combinations

  13. Thiazides: Adverse Effects and Drug Interactions • Hypotension • Hypokalemia (increases chance for arrhythmias, especially with digoxin toxicity) • Hyperglycemia, hyperlipidemia, hypercalcemia • Gout (hyperuricemia): inhibits uric acid secretion • NSAIDs can reduce antihypertensive effect of thiazides • Crossover allergies with sulfa antiinfective drugs possible because thiazides are sulfonamides • Caution with epinephrine in patients taking thiazides and digoxin

  14. Loop Diuretics • Pharmacologic class: loop diuretic • Prevents chloride reabsorption in loop of Henle; greatly increases urine output. • Increases K+, Mg+2, Ca+2 and uric acid excretion • Prototype: furosemide (Lasix) • Indications • Hypertension • Edema

  15. Potassium-Sparing Diuretics • Pharmacological class: K+-sparing diuretic • Used in combination with thiazides • Counteracts the effects of thiazides on potassium loss • Pharmacologic effects: decreases K+ excretion while increases Na+ excretion (increasing urine production) • Prototype: spironolactone (Aldactone) • Combination drugs: • HCTZ with triamterene (Dyrenium) = (Dyazide, Maxzide) • HCTZ with spironolactone (Aldactone) = (Aldactazide) • Indications: • hypertension • hypokalemia

  16. Antiadrenergic Drugs- alpha and beta blockers • Act by inhibiting sympathetic activity • Decrease HR and contractility Decrease cardiac output  decrease blood pressure • Sympathetic NS controls blood pressure by • Increasing HR • Vasoconstriction • Increasing contractility of heart • Examples: • Alpha adrenergic blockers • Beta adrenergic blockers

  17. Alpha Adrenergic Blockers • Competitive inhibitors of norepinephrine and epinephrine at alpha adrenergic receptors. • Leads to vasodilation of arteries/arterioles • Decrease PR! • Examples: • prazosin (Minipress) • terazosin (Hytrin) • doxazosin (Cardura)

  18. Beta Adrenergic Blockers • Competitive inhibitors of NE and Epi at beta adrenergic receptors • Leads to decreased HR and decreased contractility of heart • Examples: • propranolol (Inderal) • atenolol (Tenormin) • metoprolol (Lopressor) • esmolol (Brevibloc) • retaxolol (Kerlone) • penbulolol (Levatol) • sotalol (Betapace) • risoprolol (Zebeta)

  19. ACE Inhibitors = Angiotensin Converting Enzyme Inhibitors • Used in persons with normal renal function • Pharmacologic effects: • Inhibits formation of angiotensin II, thus decreasing vasoconstriction = causing vasodilation • Decreases aldosterone secretion  decreasing sodium retention and water retention = causing sodium elimination and water elimination, decreasing blood volume and decreasing blood pressure

  20. Blood Pressure Regulation • Renin-Angiotensin System (Renin-Angiotensin-Aldosterone) This endocrine pathway works to maintain blood volume in order to maintain BP. • Kidney (JG Apparatus cells) detect decrease in blood volume  secrete Renin into blood. • Renin, an enzyme, converts circulating Angiotensinogen to Angiotensin I. • As Angiotension I circulates in the blood through the lungs, an enzyme on the surface of pulmonary capillary endothelial cells, Angiotensin Converting Enzyme (ACE), converts Angiotensin I to Angiotensin II: an active hormone. Renin ACE Angiotensinogen Angiotensin I Angiotensin II

  21. Blood Pressure Regulation • Renin-Angiotensin-Aldosterone System (continued) Effects of Angiotensin II • Increased secretion of aldosterone by adrenal cortex. • Increased secretion of ADH by posterior pituitary. • Increased vasoconstriction (___ PR) • Increased thirst center activity. (__ Body fluids  __ SV)) RESULTS: Increased reabsorption of Na+ in the DCT & CT of renal tubule. Increased reabsorption of water in the DCT & CT of renal tubule. INCREASES BLOOD VOLUME  INCREASED SV HR x SV x PR  BP

  22. Angiotensin II causes the secretion/production of which 2 hormones? • Renin and aldosterone • Aldosterone and ADH • Angiotensin I and renin • Cortisol and insulin • Estrogen and testosterone

  23. ACE Inhibitors- • Side effects • Hypotension • Dry cough • others include loss of taste, rash, jaundice, hyperkalemia, renal damage • Examples: all end in –pril • enalapril (Vasotec) • captopril (Capoten • lisinopril (Zestril) • quinapril (Accupril) • ramipril (Altace) • moexepril (Univasc) • fosinopril (Monopril) • renzapril (Lotensin

  24. Calcium Channel Blockers • Mechanism: inhibits entry of calcium into cells. • Bottom line: Decrease heart rate & contractility and decrease vasoconstriction  Decrease CO and PR Decrease blood pressure • Also leads to decreased vasoconstriction • Decreased HR • Decreased contractility

  25. Calcium Channel Blockers: Pharmacologic Effects/ Indications • Coronary and peripheral vasodilation • Decreased HR • Decreased contractility Clinical Indications: HTN arrhythmias angina

  26. Calcium Channel Blockers • Examples: “rap” and “dip” • verapamil (Isoptin) • nifedipine (Procardia) • diltiazem (Cardizem) exception • nisoldipine (Sular) • amlodipine (Norvasc) • nicardipine (Cardene) • felodipine (Plendil)

  27. Angiotensin II antagonists e.g. Losartan (COZAAR) Mechanism: prevents Ang II from binding to its receptor Effects - same as ACE inhibitor without the bradykinin effect Adverse effects – same AE’s as ACE inhibitor without the dry cough and angioedema

  28. Match the antihypertensive to its category, just for fun! • Lisinopril ______ • Verapamil ______ • Prazosin ______ • Metoprolol ______ • Furosemide ______ • Spironolactone ______ • Hydroclorothiazide ______ • Losartan ______ • Calcium channel blocker • Potassium sparing diuretic • Loop diuretic • ACE inhibitor • Beta blocker • Angiotensin II blocker • Alpha-1 blocker • Thiazide diuretic

  29. Which are the most common ones??

  30. Management of Dental Patients Taking Antihypertensive Drugs • Adverse Effects: • Xerostomia • Dysgeusia • Gingival enlargement (Calcium channel blockers) • Orthostatic hypotension • Lichenoid reactions

  31. Drug Interactions of Concern • Common drug interactions with antihypertensives often occur with drugs the dental professional prescribes. • Local anesthetics with or without epinephrine • Conscious sedation of anxious patients • NSAIDS and antifungals are commonly prescribed

  32. Hypertensive Crisis- Emergency • Medication noncompliance is one of most significant factors • Thorough history, always take BP reading. Severe increase >180/120 mm Hg or acute rise after previously normal baseline can be caused by • Neurologic deficits due to stroke • Nausea/vomiting from hypertensive encephalopathy and increased intracranial pressure • Chest discomfort from MI or aortic dissection • Back pain from aortic dissection • Dyspnea from pulmonary edema • Pregnancy hypertension; pre-ecclampsia

  33. Complications associated with use of vasoconstrictors • Epinephrine – hemostatic agent with local anesthetics • Also used in retraction cord to improve overall vision and control hemorrage in taking impressions for crown and bridge • Risks of using epinephrine in hypertensive population • Acute hypertensive or hypotensive episodes, angina pectoris, arrhythmias, and MI • Epi in local anesthetics can affect hemodynamics of a patient. (recent study, 2015) • 1:80,000 can affect SBP and DBP as well as heart rate • 1:100,000 can exacerbate SBP and heart rate • 1:200,000: exacerbate heart rate

  34. Continued, vasoconstrictor complications • Continued: consider concentrations of 1:200,000 before tooth extraction to prevent significant hemodynamic changes • Use of impregnated retraction cord has been discouraged in patients with uncontrolled hypertension • 0,04 mg epi total dose for those with CV disease.

  35. Drug interactions with vasoconstrictors • Epinephrine interacts with some antihypertensive agents • Beta blocker + epi  possible hypertension and relex bradycardia • Diuretics produce hypokalemia; with epi can be exacerbated, causing arrhythmia • Epinephrine + cocaine  blood pressure spikes and fatal dysrhythmias.

  36. Bleeding Issues • Elevated BP can cause excessive bleeding • In patients who are on anticoagulants, if INR (international normalized ratio) value is <4, no need to stop anticoagulant therapy before minor surgery. • For aspirin or other antiplatelet drugs like clopidogrel, continue with procedure even if minor surgery • Various hemostatic agents can be used in the above cases

  37. Racial/Ethnicity disparity-associated hypertension • Prevalence of hypertension in African Americans is highest in the world, 41.4% of hypertensive patients. • Cause? • Access to care, poor diagnoses • Poor treatment/medication noncompliance • Socioeconomic status • Still it’s duty of health care provider to aid in prevention and education of hypertension

  38. Your client’s BP is 181/120. This person is experiencing: • Stage I hypertension • Stage II hypertension • Pre-hypertension • Normal blood pressure • Hypertensive crisis • ”White coat” hypertension

  39. Break

  40. Pharmacology of Antidepressants:Clinical Considerations

  41. Introductory information on antidepressant use • Widespread use: 21% of the 1,800 patient dental records reviewed showed antidepressant use. (Josephe et al, 2003). Watch for increased evidence of oral lesions! • Used in patients of all ages! • Used to treat many psychiatric diseases (depression, affective disease, insomnia, anxiety, panic syndrome, bipolar) • Used to treat other medical conditions like rheumatoid arthritis, dietary disorders, fibromyalgia, migraine, trigeminal neuralgia, premenstrual tension (Keene et all, 2003)

  42. Clinical Depression – sometimes confused with other causes Major depression, situational depression • postpartum depression, premenstrual dysphoric syndrome, seasonal affective disorder • side effects of some drugs (glucocorticoids, levodopa, oral contraceptives) mimic depression • B-vitamin deficiencies, thyroid disorders, Alzheimer’s disease may be misdiagnosed as depression • alcoholism and drug abuse may be misdiagnosed as depression or can be contributing factors to the development of depression

  43. Depression

More Related